Castle Biosciences, Inc.CSTLNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Above historical average.
Left:
||||
Price-to-book ratio
Latest
1.62
↑ 155% above average
Average (7y)
-2.94
Historical baseline
Range
High:3.47
Low:-22.64
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 1.62 | +9.9% |
| 2023 | 1.48 | -3.8% |
| 2022 | 1.54 | -41.3% |
| 2021 | 2.62 | -14.4% |
| 2020 | 3.06 | -11.8% |
| 2019 | 3.47 | +115.3% |
| 2018 | -22.64 | -54.3% |
| 2017 | -14.67 | - |